Lead party: Government of Canada (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Lwanda Biotech
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Grant · Deal amount: US$91,136
Lead investor/buyer: Government of Canada · Investors/buyers: Government of Canada
Legal advisers: not identified in the source record.
Source: announced 30 June 2022. Original announcement: afri-plastics.challenges.org.


